3101 August 2026Appointment of new CFOThe board of ChemoMetec has appointed Phillip Massie Price as the new CFO with effect from 3 August 2026. Phillip Massie Price joins ChemoMetec from a position as Director, Corporate Finance at Unimed, a global healthcare group. Previously, he served as Interim Group CFO at LiqTech International, Inc., listed on Nasdaq in New York, where he led Group Finance. The board has also entered into an agreement with the company's current CFO Kim Nicolajsen that he will resign from his position at the same time as Phillip Massie Price takes over. CEO Martin Helbo Behrens and CFO Phillip Massie Price will hereafter form the executive management of ChemoMetec.